Acquisitions16 Mar 2026, 07:06 pm
Rekvina Laboratories Ltd. Approves Preferential Issue of Shares and Acquisition of Radiant Parenterals Limited
AI Summary
Rekvina Laboratories Ltd. has approved a preferential issue of shares through swap of shares and cash consideration, as well as the acquisition of 100% equity share capital of Radiant Parenterals Limited for a total consideration of INR 4,62,77,500. The acquisition is expected to strengthen the Company's position in the pharmaceuticals market and create long-term shareholder value.
Key Highlights
- Rekvina Laboratories Ltd. approves preferential issue of shares for acquisition of Radiant Parenterals Limited
- Total consideration for the acquisition is INR 4,62,77,500
- The acquisition will help the Company expand its presence in the pharmaceuticals market
- The transaction is expected to be completed within 15 days from the receipt of necessary approvals
- The acquisition will be undertaken on an arm's length basis, taking into account the valuation report issued by a Registered Valuer